| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And President
1 company
Kendall Keith J is a CEO And President at Aquestive Therapeutics, Inc.. Recent SEC Form 4 filings include 9 buys and 1 sell.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2020 | AQST Aquestive Therapeutics, Inc. | CEO And President | Sell | 50,000 | $5.11 | $255,310.00 | -7.3% | |
| Aug 14, 2019 | AQST Aquestive Therapeutics, Inc. | CEO And President | Buy | 8,000 | $3.87 | $30,987.00 | +0.2% | |
| Nov 27, 2018 | AQST Aquestive Therapeutics, Inc. | CEO And President | Buy | 1,000 | $9.87 | $9,870.00 | +0.2% | |
| Nov 23, 2018 | AQST Aquestive Therapeutics, Inc. | CEO And President | Buy | 7,950 | $10.10 | $80,325.00 | +0.6% |